GLYCANEX Trademark

Trademark Overview

On Tuesday, April 21, 2020, a trademark application was filed for GLYCANEX with the United States Patent and Trademark Office. The USPTO has given the GLYCANEX trademark a serial number of 88881336. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, January 19, 2023. This trademark is owned by Moleculin Biotech, Inc.. The GLYCANEX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and products for treatment of COVID-19
glycanex

General Information

Serial Number88881336
Word MarkGLYCANEX
Filing DateTuesday, April 21, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, January 19, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesPharmaceutical preparations and products for treatment of COVID-19

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, April 30, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMoleculin Biotech, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHouston, TX 77007

Trademark Events

Event DateEvent Description
Thursday, January 19, 2023ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Thursday, January 19, 2023ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, January 19, 2023ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, June 30, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NON-FINAL ACTION E-MAILED
Thursday, June 30, 2022NON-FINAL ACTION WRITTEN
Thursday, December 16, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, December 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, June 12, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, June 12, 2021LETTER OF SUSPENSION E-MAILED
Saturday, June 12, 2021SUSPENSION LETTER WRITTEN
Thursday, April 29, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 28, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, April 28, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, April 28, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, April 28, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, April 28, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, April 28, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, October 28, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION E-MAILED
Wednesday, October 28, 2020NON-FINAL ACTION WRITTEN
Tuesday, October 20, 2020ASSIGNED TO EXAMINER
Thursday, April 30, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 24, 2020NEW APPLICATION ENTERED

Related Keywords

glycanex covid treatment products preparations pharmaceutical